(16617218), D. O. K., (16617221), S. P., (16617224), Y. S., (16617227), M. J. S., (16617230), L. B., (11099556), J. O. B., & (16617233), J. L. (2025). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors.
Citação norma Chicago(16617218), David Olayinka Kamson, Sushant Puri (16617221), Yingying Sang (16617224), Meihui Jessica Shi (16617227), Lindsay Blair (16617230), Jaishri O. Blakeley (11099556), and John Laterra (16617233). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.
Citação norma MLA(16617218), David Olayinka Kamson, et al. Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.